Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus

Journal of Virology

Volumn 87, Issue 9, 2013, Pages 5300-5304

  Zielecki, Florian ^a   Weber, Michaela ^a   Eickmann, Markus ^a   Spiegelberg, Larissa ^a   Zaki, Ali Moh ^b   Matrosovich, Mikhail ^a   Becker, Stephan ^a   Weber, Friedemann ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b DR SOLIMAN FAKEEH HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; INTERFERON BETA SERINE; INTERFERON REGULATORY FACTOR 3;

AGMK CELL; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; CORONAVIRUS INFECTION; HOST RANGE; HUMAN; HUMAN CELL; HUMAN CORONAVIRUS ERASMUS MEDICAL CENTER; INNATE IMMUNITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TROPISM; VIRAL RESPIRATORY TRACT INFECTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CELL LINE; CORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; PRIMATES; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL TROPISM; VIRUS REPLICATION;

CORONAVIRUS; SARS CORONAVIRUS;

EID: 84876310574     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03496-12     Document Type: Article

References (38)

1. Bermingham A, Chand M, Brown C, Aarons E, Tong C, Langrish C, Hoschler K, Brown K, Galiano M, Myers R, Pebody R, Green H, Boddington N, Gopal R, Price N, Newsholme W, Drosten C, Fouchier R, Zambon M. 2012. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 17(40):pii=20290. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20290.
2. Danielsson N, on behalf of the ECDC Internal Response Team, Catchpole M. 2012. Novel coronavirus associated with severe respiratory disease: case definition and public health measures. Euro Surveill. 17(39): pii=20282. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20282.
3. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367:1814-1820.
4. Butler D. 2012. Clusters of coronavirus cases put scientists on alert. Nature 492:166-167.
5. Health Protection Agency. 15 February 2013, posting date. Third case of novel coronavirus infection identified in family cluster. Health Protection Agency, London, United Kingdom. http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1317138119464.
6. van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3(6):e00473-12. doi:10.1128/mBio.00473-12.
7. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. 2003. The severe acute respiratory syndrome. N. Engl. J. Med. 349:2431-2441.
8. Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB, Jr. 2005. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol. 79:14614-14621.
9. Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, Pickles RJ. 2005. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J. Virol. 79:15511-15524.
10. Thiel V, Weber F. 2008. Interferon and cytokine responses to SARScoronavirus infection. Cytokine Growth Factor Rev. 19:121-132.
11. Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7:439-450.
12. Gray TE, Guzman K, Davis CW, Abdullah LH, Nettesheim P. 1996. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 14:104-112.
13. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. U.S.A. 101: 4620-4624.
14. Matrosovich M, Matrosovich T, Uhlendorff J, Garten W, Klenk HD. 2007. Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. 361:384-390.
15. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
16. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
17. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. 2003. Treatment of SARS with human interferons. 362:293-294.
18. Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, Van Riel D, De Jong T, Itamura S, Chan KH, Tashiro M, Osterhaus AD. 2004. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10:290-293.
19. Spiegel M, Pichlmair A, Mühlberger E, Haller O, Weber F. 2004. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA. J. Clin. Virol. 30:211-213.
20. Kuri T, Eriksson KK, Putics A, Zust R, Snijder EJ, Davidson AD, Siddell SG, Thiel V, Ziebuhr J, Weber F. 2011. The ADP-ribose-1"-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses. J. Gen. Virol. 92:1899-1905.
21. Krahling V, Stein DA, Spiegel M, Weber F, Muhlberger E. 2009. Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity. J. Virol. 83:2298-2309.
22. Ng ML, Tan SH, See EE, Ooi EE, Ling AE. 2003. Proliferative growth of SARS coronavirus in Vero E6 cells. J. Gen. Virol. 84:3291-3303.
23. Tseng CT, Tseng J, Perrone L, Worthy M, Popov V, Peters CJ. 2005. Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J. Virol. 79:9470-9479.
24. Spiegel M, Pichlmair A, Martinez-Sobrido L, Cros J, Garcia-Sastre A, Haller O, Weber F. 2005. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol. 79:2079-2086.
25. Spiegel M, Weber F. 2006. Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virol. J. 3:17. doi:10.1186/1743-422X-3-17.
26. Overby AK, Popov VL, Niedrig M, Weber F. 2010. Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J. Virol. 84:8470-8483.
27. Habjan M, Penski N, Spiegel M, Weber F. 2008. T7 RNA polymerasedependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J. Gen. Virol. 89:2157-2166.
28. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. 2007. Multiple antiinterferon actions of the influenza A virus NS1 protein. J. Virol. 81:7011-7021.
29. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:5059-5064.
30. Hiscott J. 2007. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282:15325-15329.
31. Muller MA, Raj VS, Muth D, Meyer B, Kallies S, Smits SL, Wollny R, Bestebroer TM, Specht S, Suliman T, Zimmermann K, Binger T, Eckerle I, Tschapka M, Zaki AM, Osterhaus ADME, Fouchier RA, Haagmans BL, Drosten C. 2012. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. mBio 3(6):e00515-12. doi:10.1128/mBio.00515-12.
32. Boisson-Dupuis S, Kong XF, Okada S, Cypowyj S, Puel A, Abel L, Casanova JL. 2012. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 24:364-378.
33. Pestka S. 2007. The interferons: 50 years after their discovery, there is much more to learn. J. Biol. Chem. 282:20047-20051.
34. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976.
35. Bird BH, Bawiec DA, Ksiazek TG, Shoemaker TR, Nichol ST. 2007. Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus. J. Clin. Microbiol. 45:3506-3513.
36. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, Muth D, Muller MA, Drexler JF, Zambon M, Osterhaus AD, Fouchier RM, Drosten C. 2012. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 17(39): pii=20285. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20285.
37. Weidmann M, Zanotto PM, Weber F, Spiegel M, Brodt HR, Hufert FT. 2004. High-efficiency detection of severe acute respiratory syndrome virus genetic material. J. Clin. Microbiol. 42:2771-2773.
38. Kuri T, Zhang X, Habjan M, Martinez-Sobrido L, Garcia-Sastre A, Yuan Z, Weber F. 2009. Interferon priming enables cells to partially overturn the SARS-coronavirus-induced block in innate immune activation. J. Gen. Virol. 90:2686-2694.